BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pathmanathan I, Ahmedov S, Pevzner E, Anyalechi G, Modi S, Kirking H, Cavanaugh JS. TB preventive therapy for people living with HIV: key considerations for scale-up in resource-limited settings. Int J Tuberc Lung Dis 2018;22:596-605. [PMID: 29862942 DOI: 10.5588/ijtld.17.0758] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
Number Citing Articles
1 Torpey K, Agyei-Nkansah A, Ogyiri L, Forson A, Lartey M, Ampofo W, Akamah J, Puplampu P. Management of TB/HIV co-infection: the state of the evidence. Ghana Med J 2020;54:186-96. [PMID: 33883764 DOI: 10.4314/gmj.v54i3.10] [Reference Citation Analysis]
2 Ngugi SK, Muiruri P, Odero T, Gachuno O. Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study. BMC Infect Dis 2020;20:294. [PMID: 32664847 DOI: 10.1186/s12879-020-05011-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
3 Buck WC, Nguyen H, Siapka M, Basu L, Greenberg Cowan J, De Deus MI, Gleason M, Ferreira F, Xavier C, Jose B, Muthemba C, Simione B, Kerndt P. Integrated TB and HIV care for Mozambican children: temporal trends, site-level determinants of performance, and recommendations for improved TB preventive treatment. AIDS Res Ther 2021;18:3. [PMID: 33422091 DOI: 10.1186/s12981-020-00325-9] [Reference Citation Analysis]
4 de Vries G, van de Berg S, van Dam A, Hasanova S, Pareek M, van der Werf MJ, Podlekareva DN. Collaborative tuberculosis/HIV activities in the European Region. ERJ Open Res 2021;7:00721-2020. [PMID: 33532469 DOI: 10.1183/23120541.00721-2020] [Reference Citation Analysis]
5 Harries AD, Kumar AMV, Satyanarayana S, Takarinda KC, Timire C, Dlodlo RA. Treatment for latent tuberculosis infection in low- and middle-income countries: progress and challenges with implementation and scale-up. Expert Rev Respir Med 2020;14:195-208. [PMID: 31760848 DOI: 10.1080/17476348.2020.1694907] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Auld AF, Kerkhoff AD, Hanifa Y, Wood R, Charalambous S, Liu Y, Agizew T, Mathoma A, Boyd R, Date A, Shiraishi RW, Bicego G, Mathebula-Modongo U, Alexander H, Serumola C, Rankgoane-Pono G, Pono P, Finlay A, Shepherd JC, Ellerbrock TV, Grant AD, Fielding K. Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study. PLoS Med 2021;18:e1003739. [PMID: 34491987 DOI: 10.1371/journal.pmed.1003739] [Reference Citation Analysis]
7 Roscoe C, Lockhart C, de Klerk M, Baughman A, Agolory S, Gawanab M, Menzies H, Jonas A, Salomo N, Taffa N, Lowrance D, Robsky K, Tollefson D, Pevzner E, Hamunime N, Mavhunga F, Mungunda H. Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis. BMC Public Health 2020;20:1838. [PMID: 33261569 DOI: 10.1186/s12889-020-09902-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 LaCourse SM, Wagner AD, Cranmer LM, Copeland A, Maleche-Obimbo E, Richardson BA, Matemo D, Kinuthia J, John-Stewart G. Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women. J Acquir Immune Defic Syndr 2019;82:41-5. [PMID: 31408031 DOI: 10.1097/QAI.0000000000002086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Gersh JK, Barnabas RV, Matemo D, Kinuthia J, Feldman Z, Lacourse SM, Mecha J, Warr AJ, Kamene M, Horne DJ. Pulmonary tuberculosis screening in anti-retroviral treated adults living with HIV in Kenya. BMC Infect Dis 2021;21:218. [PMID: 33632173 DOI: 10.1186/s12879-021-05916-z] [Reference Citation Analysis]
10 Riccardi N, Villa S, Giacomelli A, Diaw MM, Ndiaye M, Gning L, Robbiano M, Alagna R, Saderi L, Biagio AD, Bassetti M, Cirillo DM, Sotgiu G, Codecasa LR, Sarr M, Besozzi G. Tuberculosis treatment outcomes in a rural area of Senegal: a decade of experience from 2010 to 2019 by StopTB Italia. Future Microbiol 2021;16:399-407. [PMID: 33847143 DOI: 10.2217/fmb-2020-0238] [Reference Citation Analysis]
11 Melgar M, Nichols C, Cavanaugh JS, Kirking HL, Surie D, Date A, Ahmedov S, Maloney S, Fukunaga R; CDC Country Offices’ Tuberculosis/HIV Advisors., National Ministries and Departments of Health Tuberculosis Program Managers. Tuberculosis Preventive Treatment Scale-Up Among Antiretroviral Therapy Patients - 16 Countries Supported by the U.S. President's Emergency Plan for AIDS Relief, 2017-2019. MMWR Morb Mortal Wkly Rep 2020;69:329-34. [PMID: 32214084 DOI: 10.15585/mmwr.mm6912a3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
12 González Fernández L, Casas EC, Singh S, Churchyard GJ, Brigden G, Gotuzzo E, Vandevelde W, Sahu S, Ahmedov S, Kamarulzaman A, Ponce-de-León A, Grinsztejn B, Swindells S. New opportunities in tuberculosis prevention: implications for people living with HIV. J Int AIDS Soc 2020;23:e25438. [PMID: 31913556 DOI: 10.1002/jia2.25438] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
13 Boyd AT, Odume B, Sidibe K, Onotu D, Ogbanufe O, Mgbakor I, Swaminathan M. Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019. J Acquir Immune Defic Syndr 2020;85:450-3. [PMID: 33136743 DOI: 10.1097/QAI.0000000000002483] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Paradkar M, Padmapriyadarsini C, Jain D, Shivakumar SVBY, Thiruvengadam K, Gupte AN, Thomas B, Kinikar A, Sekar K, Bharadwaj R, Dolla CK, Gaikwad S, Elilarasi S, Lokhande R, Reddy D, Murali L, Kulkarni V, Pradhan N, Hanna LE, Pattabiraman S, Kohli R, S R, Suryavanshi N, B M S, Cox SR, Selvaraju S, Gupte N, Mave V, Gupta A, Bollinger RC; CTRIUMPH-RePORT India Study Team. Tuberculosis preventive treatment should be considered for all household contacts of pulmonary tuberculosis patients in India. PLoS One 2020;15:e0236743. [PMID: 32726367 DOI: 10.1371/journal.pone.0236743] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Fukunaga R, Lowrance D, MacNeil A, Al-Samarrai T, Cavanaugh J, Baddeley A, Nichols C, Peterson M, Ahmedov S, Singh V, Edwards CG, Jain S, Date A, Maloney SA. Collect Once, Use Many Times: Attaining Unified Metrics for Tuberculosis Preventive Treatment for People Living With HIV. JMIR Public Health Surveill 2021;7:e27013. [PMID: 33929335 DOI: 10.2196/27013] [Reference Citation Analysis]
16 Nabity SA, Gunde LJ, Surie D, Shiraishi RW, Kirking HL, Maida A, Auld AF, Odo M, Jahn A, Nyirenda RK, Oeltmann JE. Early-phase scale-up of isoniazid preventive therapy for people living with HIV in two districts in Malawi (2017). PLoS One 2021;16:e0248115. [PMID: 33793577 DOI: 10.1371/journal.pone.0248115] [Reference Citation Analysis]
17 Melgar M, Shiraishi RW, Tende C, Mwanza S, Mulenga J, Khondowe S, Mwakazanga D, Kapungu K, Tembo M, Nota A, Lungu P, Moore B, Podewils LJ. Assessment of the tuberculosis case-finding and prevention cascade among people living with HIV in Zambia - 2018: a cross-sectional cluster survey. BMC Public Health 2021;21:859. [PMID: 33947361 DOI: 10.1186/s12889-021-10929-z] [Reference Citation Analysis]